American International Group’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,653	Closed	-$838K	–	1438
2024 Q1	$838K	Buy	12,653 +1,465	+13%	+$86.9K	﹤0.01%	1395
2023 Q4	$445K	Sell	11,188 -45	-0.4%	-$1.41K	﹤0.01%	1739
2023 Q3	$358K	Buy	11,233 +399	+4%	+$14.9K	﹤0.01%	1797
2023 Q2	$435K	Buy	10,834 +1,547	+17%	+$67.8K	﹤0.01%	1728
2023 Q1	$397K	Buy	9,287 +185	+2%	+$9.34K	﹤0.01%	1734
2022 Q4	$437K	Buy	9,102 +560	+7%	+$26.2K	﹤0.01%	1666
2022 Q3	$321K	Buy	8,542 +684	+9%	+$23.7K	﹤0.01%	1856
2022 Q2	$217K	Buy	7,858 +110	+1%	+$4.83K	﹤0.01%	2133
2022 Q1	$421K	Sell	7,748 -545	-7%	-$28K	﹤0.01%	1817
2021 Q4	$485K	Sell	8,293 -248	-3%	-$12.4K	﹤0.01%	1828
2021 Q3	$338K	Sell	8,541 -203	-2%	-$7.22K	﹤0.01%	2097
2021 Q2	$371	Buy	8,744 +1,013	+13%	+$54.9K	﹤0.01%	2118
2021 Q1	$476	Buy	7,731 +150	+2%	+$9.5K	﹤0.01%	1870
2020 Q4	$535	Buy	7,581 +3,416	+82%	+$215K	﹤0.01%	1707
2020 Q3	$161K	Sell	4,165 -96	-2%	-$3.81K	﹤0.01%	2267
2020 Q2	$160K	Buy	+4,261	New	+$131K	﹤0.01%	2256